Investors in clinical trial technologies face an unprecedented array of excellent products that meet compelling industry needs. Realizing that potential requires deep industry and customer knowledge to evaluate opportunities and mitigate risks. I offer specialized consulting services to provide venture capital and equity investors with the insights needed to make informed decisions and maximize returns.
Services include:
- Landscape Analysis: Offering a comprehensive view of regulatory context, industry trends, competitive dynamics, and technology shifts to evaluate investment opportunities.
- Technology and Product Assessment: Evaluating the capabilities, scalability, and differentiation of target companies’ technologies, ensuring alignment with biopharma needs and industry standards.
- Operational Due Diligence: Assessing the management teams, operational frameworks, and readiness of companies to scale in the complex drug development and sponsor environment.
- Post-Investment Strategy: Advising on value creation strategies to help portfolio companies succeed, from refining go-to-market approaches to supporting partnerships with sponsors and CROs.
With my expertise, equity investors gain a trusted advisor to bridge the gap between technology innovation and clinical trial execution, unlocking value for both their portfolios and the industry.
futurpositif 